
Cabotib 40 Tablet
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Cabozantinib (40mg)
Overview Cabotib 40 Tablet
Lenvima 40mg tablets are tyrosine kinase inhibitors prescribed for liver, kidney, and thyroid cancers. Administer this medication on an empty stomach, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's instructions; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue only under medical guidance. Common side effects include tiredness, nausea, appetite loss, altered taste, and diarrhea. High blood pressure is a potential side effect, necessitating regular monitoring. Report severe skin reactions like rashes, or hand/foot pain, swelling, or redness immediately. Inform your doctor of pre-existing heart disease, liver or kidney impairment, or hypertension before commencing treatment. Disclose all medications to your healthcare provider due to potential drug interactions. This medication is contraindicated during pregnancy and breastfeeding; effective contraception is crucial for both partners throughout treatment.
Primary Ingredients of Cabotib 40 Tablet
There is no text provided to rephrase.
Uses of Cabotib 40 Tablet
Therapeutic approaches for hepatic, renal, and thyroid malignancies.
Major Benefits of Cabotib 40 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Cabotib 40 Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Cabotib 40 Tablet:
- Fatigue
- Nausea
- Diarrhea
- Vomiting
- Stomatitis (Inflammation of the mouth)
- High blood pressure
- Decreased appetite
- Taste change
- Low blood platelets
- Anemia (low number of red blood cells)
- Palmar-plantar erythrodysesthesia syndrome
- Decrease in body weight
- Increased liver enzymes
- Dyspepsia
How to use Cabotib 40 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Cabotib 40 Tablet whole; do not crush, chew, or break it. Administer on an empty stomach.
How Cabotib 40 Tablet works:
Cabotib 40 Tablets inhibit a faulty protein responsible for cancer cell proliferation, thus curbing or halting tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Cabotib 40 Tablet may be unsafe; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Cabotib 40 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Cabotib 40 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Cabotib 40 Tablet on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Cabotib 40 mg tablets pose no safety concerns for patients with renal impairment; dosage modification is unnecessary.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Cabotib 40 mg tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Cabotib 40 Tablet :
NA
Facts to Know About Cabotib 40 Tablet
| Label | Value |
|---|---|
| Chemical Type | Aryl Ethers |
| Developing Habits | No. |
| Treatment Category | Cancer Drugs |
| Actions | Kinase inhibitors targeting tyrosine |
